Algernon Pharmaceuticals Secures Funding Through Private Placement

Algernon Pharmaceuticals (TSE:AGN) has released an update.

Algernon Pharmaceuticals, a Canadian drug development firm, has successfully completed a non-brokered private placement, raising $235,200 for working capital purposes. Insider participation added $60,000 to the raise, classified as a ‘related party transaction,’ but complied with regulatory exemptions due to the transaction’s size relative to the company’s market cap.

For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.